Effectiveness of Transcranial Magnetic Stimulation Treatment in Patients Diagnosed With Postpolio Syndrome: A Randomized Controlled Double-Blind Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-01

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is planned to include a minimum of 26 patients with paralytic poliomyelitis who meet the PPS diagnostic criteria (1). Patients will be randomized into two groups, and one group will receive only the exercise therapy used in standard treatment, while the other group will receive Transcranial Magnetic Stimulation (TMS) therapy in addition to exercise. TMS will be applied to the study group 5 times a week for 2 weeks, for a total of 10 sessions. The protocol to be applied during the study will be set to 1 Hz, and each session will last 15 minutes. All participants will be evaluated with muscle strength (manual muscle testing), 6-minute walking test, polio-related problems inventory, VAS pain, VAS fatigue, fatigue severity scale, Beck Depression Inventory, Nottingham health profile scales before, at the end of treatment, and at the end of the 3rd month. As a result of the evaluation, the potential positive effects of TMS on patients with PPS will be measured and evidence-based data for the use of this treatment modality in patients with PPS will be obtained. This study will be the first to evaluate the effectiveness of TMS in a controlled manner in a patient group with PPS. As a result of the evaluation, the potential positive effects of TMS on patients with PPS will be measured and evidence-based data will be obtained for the use of this treatment modality in patients with PPS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of TMS on Neuropathic Pain for Patients With Sci

NCT07293780

Spinal Cord Injury Neuropathic Pain

RECRUITING NA

Repetitive Transcranial Magnetic Stimulation Therapy in Spinal Cord Injury Related Neuropathic Pain

NCT06726954

Spinal Cord Injuries Neuropathic Pain

RECRUITING NA

Effects of Transcranial Magnetic Stimulation in Incomplete Spinal Cord Injury

NCT02899637

Spinal Cord Injury

UNKNOWN NA

Effects of Trans-spinal Magnetic Stimulation on Cortical Excitability in Healthy Individuals

NCT07026760

Healthy Individuals

RECRUITING PHASE1

Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients

NCT05645003

Spinal Cord Injuries Neuropathic Pain Neurological Diseases or Conditions

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpolio Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SHAM

5 sessions per week; 2 weeks, 90% RMT (resting motor threshold), 1 Hz, 15 min TMS will be applied, but treatment During the procedure, the application head of the device is turned in the opposite direction so that the patient receives TMS treatment.

effect, but you hear the operating sound of the device and will spend it in the laboratory

Also, home exercise program:

quadriceps strengthening and knee isometric exercises

Group Type SHAM_COMPARATOR

TMS

Intervention Type DEVICE

Magstim ,Rapid 2

INTERVENTION

5 sessions/week, 2 weeks, 90% RMT (resting motor threshold), 1 Hz, 15 min TMS application to patients As the application point, the Cz point on the EEG map, contralateral to the affected extremity, will be taken

Also, home exercise program:

quadriceps strengthening and knee isometric exercises

Group Type EXPERIMENTAL

TMS

Intervention Type DEVICE

Magstim ,Rapid 2

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TMS

Magstim ,Rapid 2

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\-

Exclusion Criteria

* Presence of another disease that may be associated with the symptoms
* Inability to ambulate independently
* Presence of a neurological, psychiatric or vision-related problem that may prevent the patient from answering the questionnaires
* Presence of ferromagnetic material implanted in the body
* Organic brain pathology (vascular, traumatic, tumoral, etc.)
* History of use of drugs that lower the seizure threshold (if not receiving antiepileptic treatment)
* Severe or recent heart disease
* Alcoholism
* Pregnancy

Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No